ACR BI-RADS Assessment Category 4 Subdivisions in Diagnostic Mammography: Utilization and Outcomes in the National Mammography Database

Purpose To determine the utilization and positive predictive value (PPV) of the American College of Radiology (ACR) Breast Imaging Data and Reporting System (BI-RADS) category 4 subdivisions in diagnostic mammography in the National Mammography Database (NMD). Materials and Methods This study involv...

Full description

Saved in:
Bibliographic Details
Published in:Radiology Vol. 287; no. 2; p. 416
Main Authors: Elezaby, Mai, Li, Geng, Bhargavan-Chatfield, Mythreyi, Burnside, Elizabeth S, DeMartini, Wendy B
Format: Journal Article
Language:English
Published: United States 01.05.2018
Subjects:
ISSN:1527-1315, 1527-1315
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Purpose To determine the utilization and positive predictive value (PPV) of the American College of Radiology (ACR) Breast Imaging Data and Reporting System (BI-RADS) category 4 subdivisions in diagnostic mammography in the National Mammography Database (NMD). Materials and Methods This study involved retrospective review of diagnostic mammography data submitted to the NMD from January 1, 2008 to December 30, 2014. Utilization rates of BI-RADS category 4 subdivisions were compared by year, facility (type, location, census region), and examination (indication, finding type) characteristics. PPV3 (positive predictive value for biopsies performed) was calculated overall and according to category 4 subdivision. The χ test was used to test for significant associations. Results Of 1 309 950 diagnostic mammograms, 125 447 (9.6%) were category 4, of which 33.3% (41 841 of 125 447) were subdivided. Subdivision utilization rates were higher (P < .001) in practices that were community, suburban, or in the West; for examination indication of prior history of breast cancer; and for the imaging finding of architectural distortion. Of 41 841 category 4 subdivided examinations, 4A constituted 55.6% (23 258 of 41 841) of the examinations; 4B, 31.8% (13 302 of 41 841) of the examinations; and 4C, 12.6% (5281 of 41 841) of the examinations. Pathologic outcomes were available in 91 563 examinations, and overall category 4 PPV3 was 21.1% (19 285 of 91 563). There was a statistically significant difference in PPV3 according to category 4 subdivision (P < .001): The PPV of 4A was 7.6% (1274 of 16 784), that of 4B was 22% (2317 of 10 408), and that of 4C was 69.3% (2839 of 4099). Conclusion Although BI-RADS suggests their use, subdivisions were utilized in the minority (33.3% [41 841 of 125 447]) of category 4 diagnostic mammograms, with variability based on facility and examination characteristics. When subdivisions were used, PPV3s were in BI-RADS-specified malignancy ranges. This analysis supports the use of subdivisions in broad practice and, given benefits for patient care, should motivate increased utilization. RSNA, 2018 Online supplemental material is available for this article.
AbstractList Purpose To determine the utilization and positive predictive value (PPV) of the American College of Radiology (ACR) Breast Imaging Data and Reporting System (BI-RADS) category 4 subdivisions in diagnostic mammography in the National Mammography Database (NMD). Materials and Methods This study involved retrospective review of diagnostic mammography data submitted to the NMD from January 1, 2008 to December 30, 2014. Utilization rates of BI-RADS category 4 subdivisions were compared by year, facility (type, location, census region), and examination (indication, finding type) characteristics. PPV3 (positive predictive value for biopsies performed) was calculated overall and according to category 4 subdivision. The χ test was used to test for significant associations. Results Of 1 309 950 diagnostic mammograms, 125 447 (9.6%) were category 4, of which 33.3% (41 841 of 125 447) were subdivided. Subdivision utilization rates were higher (P < .001) in practices that were community, suburban, or in the West; for examination indication of prior history of breast cancer; and for the imaging finding of architectural distortion. Of 41 841 category 4 subdivided examinations, 4A constituted 55.6% (23 258 of 41 841) of the examinations; 4B, 31.8% (13 302 of 41 841) of the examinations; and 4C, 12.6% (5281 of 41 841) of the examinations. Pathologic outcomes were available in 91 563 examinations, and overall category 4 PPV3 was 21.1% (19 285 of 91 563). There was a statistically significant difference in PPV3 according to category 4 subdivision (P < .001): The PPV of 4A was 7.6% (1274 of 16 784), that of 4B was 22% (2317 of 10 408), and that of 4C was 69.3% (2839 of 4099). Conclusion Although BI-RADS suggests their use, subdivisions were utilized in the minority (33.3% [41 841 of 125 447]) of category 4 diagnostic mammograms, with variability based on facility and examination characteristics. When subdivisions were used, PPV3s were in BI-RADS-specified malignancy ranges. This analysis supports the use of subdivisions in broad practice and, given benefits for patient care, should motivate increased utilization. RSNA, 2018 Online supplemental material is available for this article.
Purpose To determine the utilization and positive predictive value (PPV) of the American College of Radiology (ACR) Breast Imaging Data and Reporting System (BI-RADS) category 4 subdivisions in diagnostic mammography in the National Mammography Database (NMD). Materials and Methods This study involved retrospective review of diagnostic mammography data submitted to the NMD from January 1, 2008 to December 30, 2014. Utilization rates of BI-RADS category 4 subdivisions were compared by year, facility (type, location, census region), and examination (indication, finding type) characteristics. PPV3 (positive predictive value for biopsies performed) was calculated overall and according to category 4 subdivision. The χ2 test was used to test for significant associations. Results Of 1 309 950 diagnostic mammograms, 125 447 (9.6%) were category 4, of which 33.3% (41 841 of 125 447) were subdivided. Subdivision utilization rates were higher (P < .001) in practices that were community, suburban, or in the West; for examination indication of prior history of breast cancer; and for the imaging finding of architectural distortion. Of 41 841 category 4 subdivided examinations, 4A constituted 55.6% (23 258 of 41 841) of the examinations; 4B, 31.8% (13 302 of 41 841) of the examinations; and 4C, 12.6% (5281 of 41 841) of the examinations. Pathologic outcomes were available in 91 563 examinations, and overall category 4 PPV3 was 21.1% (19 285 of 91 563). There was a statistically significant difference in PPV3 according to category 4 subdivision (P < .001): The PPV of 4A was 7.6% (1274 of 16 784), that of 4B was 22% (2317 of 10 408), and that of 4C was 69.3% (2839 of 4099). Conclusion Although BI-RADS suggests their use, subdivisions were utilized in the minority (33.3% [41 841 of 125 447]) of category 4 diagnostic mammograms, with variability based on facility and examination characteristics. When subdivisions were used, PPV3s were in BI-RADS-specified malignancy ranges. This analysis supports the use of subdivisions in broad practice and, given benefits for patient care, should motivate increased utilization. © RSNA, 2018 Online supplemental material is available for this article.Purpose To determine the utilization and positive predictive value (PPV) of the American College of Radiology (ACR) Breast Imaging Data and Reporting System (BI-RADS) category 4 subdivisions in diagnostic mammography in the National Mammography Database (NMD). Materials and Methods This study involved retrospective review of diagnostic mammography data submitted to the NMD from January 1, 2008 to December 30, 2014. Utilization rates of BI-RADS category 4 subdivisions were compared by year, facility (type, location, census region), and examination (indication, finding type) characteristics. PPV3 (positive predictive value for biopsies performed) was calculated overall and according to category 4 subdivision. The χ2 test was used to test for significant associations. Results Of 1 309 950 diagnostic mammograms, 125 447 (9.6%) were category 4, of which 33.3% (41 841 of 125 447) were subdivided. Subdivision utilization rates were higher (P < .001) in practices that were community, suburban, or in the West; for examination indication of prior history of breast cancer; and for the imaging finding of architectural distortion. Of 41 841 category 4 subdivided examinations, 4A constituted 55.6% (23 258 of 41 841) of the examinations; 4B, 31.8% (13 302 of 41 841) of the examinations; and 4C, 12.6% (5281 of 41 841) of the examinations. Pathologic outcomes were available in 91 563 examinations, and overall category 4 PPV3 was 21.1% (19 285 of 91 563). There was a statistically significant difference in PPV3 according to category 4 subdivision (P < .001): The PPV of 4A was 7.6% (1274 of 16 784), that of 4B was 22% (2317 of 10 408), and that of 4C was 69.3% (2839 of 4099). Conclusion Although BI-RADS suggests their use, subdivisions were utilized in the minority (33.3% [41 841 of 125 447]) of category 4 diagnostic mammograms, with variability based on facility and examination characteristics. When subdivisions were used, PPV3s were in BI-RADS-specified malignancy ranges. This analysis supports the use of subdivisions in broad practice and, given benefits for patient care, should motivate increased utilization. © RSNA, 2018 Online supplemental material is available for this article.
Author Bhargavan-Chatfield, Mythreyi
Li, Geng
Elezaby, Mai
Burnside, Elizabeth S
DeMartini, Wendy B
Author_xml – sequence: 1
  givenname: Mai
  surname: Elezaby
  fullname: Elezaby, Mai
  organization: From the Department of Radiology (M.E., E.S.B.), Department of Biostatistics and Medical Informatics (G.L.), and Carbone Comprehensive Cancer Center (E.S.B.), University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI 53792; American College of Radiology, Reston, Va (M.B.); and Department of Radiology, Stanford University School of Medicine, Stanford, Calif (W.B.D.)
– sequence: 2
  givenname: Geng
  surname: Li
  fullname: Li, Geng
  organization: From the Department of Radiology (M.E., E.S.B.), Department of Biostatistics and Medical Informatics (G.L.), and Carbone Comprehensive Cancer Center (E.S.B.), University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI 53792; American College of Radiology, Reston, Va (M.B.); and Department of Radiology, Stanford University School of Medicine, Stanford, Calif (W.B.D.)
– sequence: 3
  givenname: Mythreyi
  surname: Bhargavan-Chatfield
  fullname: Bhargavan-Chatfield, Mythreyi
  organization: From the Department of Radiology (M.E., E.S.B.), Department of Biostatistics and Medical Informatics (G.L.), and Carbone Comprehensive Cancer Center (E.S.B.), University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI 53792; American College of Radiology, Reston, Va (M.B.); and Department of Radiology, Stanford University School of Medicine, Stanford, Calif (W.B.D.)
– sequence: 4
  givenname: Elizabeth S
  surname: Burnside
  fullname: Burnside, Elizabeth S
  organization: From the Department of Radiology (M.E., E.S.B.), Department of Biostatistics and Medical Informatics (G.L.), and Carbone Comprehensive Cancer Center (E.S.B.), University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI 53792; American College of Radiology, Reston, Va (M.B.); and Department of Radiology, Stanford University School of Medicine, Stanford, Calif (W.B.D.)
– sequence: 5
  givenname: Wendy B
  surname: DeMartini
  fullname: DeMartini, Wendy B
  organization: From the Department of Radiology (M.E., E.S.B.), Department of Biostatistics and Medical Informatics (G.L.), and Carbone Comprehensive Cancer Center (E.S.B.), University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI 53792; American College of Radiology, Reston, Va (M.B.); and Department of Radiology, Stanford University School of Medicine, Stanford, Calif (W.B.D.)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29315061$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1OwzAQhC1URH_gAbggH7mk2E5cJ9xCyk-lQqWWnqNNYrdGSVxiB6m8AK9NVIrUy-xq9ps9zBD1alNLhK4pGVMahHcNFNqUY0aooIIIQc7QgHImPOpT3jvZ-2ho7QchNOChuEB9FnUmmdAB-omTJX6Yect4usKxtdLaStYOJ-DkxjR7HOBVmxX6S1ttaot1jacaNrWxTuf4FarKbBrYbff3eO10qb_BdRyGusCL1uWmkoeM20r8djhBeZrCU3CQgZWX6FxBaeXVcY7Q-unxPXnx5ovnWRLPvdyPIucp5RMZMih8xYmiGS9AdEJEFEmaTZjwVSalz4VQijFVZCwUhOQ8CkPwc-azEbr9-7trzGcrrUsrbXNZllBL09qURmHEecAmokNvjmibVbJId42uoNmn_-WxXz-LdVY
CitedBy_id crossref_primary_10_1097_JS9_0000000000001186
crossref_primary_10_2147_CMAR_S242101
crossref_primary_10_1136_bmjopen_2021_050457
crossref_primary_10_1186_s13244_025_01990_y
crossref_primary_10_1007_s10278_023_00798_w
crossref_primary_10_1007_s11547_024_01804_z
crossref_primary_10_1186_s12880_023_01023_4
crossref_primary_10_3389_fonc_2024_1399296
crossref_primary_10_1007_s11547_022_01583_5
crossref_primary_10_3348_jksr_2021_0105
crossref_primary_10_1016_j_compmedimag_2020_101829
crossref_primary_10_1016_j_acra_2019_07_020
crossref_primary_10_1007_s13193_020_01274_5
crossref_primary_10_12688_f1000research_142468_1
crossref_primary_10_1002_cam4_2877
crossref_primary_10_3348_kjr_2019_0262
crossref_primary_10_1016_j_ejrad_2021_110029
crossref_primary_10_1016_j_acra_2024_12_051
crossref_primary_10_1177_0846537120983122
crossref_primary_10_1097_RCT_0000000000001108
crossref_primary_10_3390_diagnostics12010172
crossref_primary_10_1016_j_ejrad_2020_108982
crossref_primary_10_1002_ima_22724
crossref_primary_10_1186_s12938_023_01115_w
crossref_primary_10_1177_03000605221139712
crossref_primary_10_3390_diagnostics13030540
crossref_primary_10_1148_ryai_220259
crossref_primary_10_3389_fonc_2021_634752
crossref_primary_10_3389_fonc_2021_611471
crossref_primary_10_2147_IJWH_S539131
crossref_primary_10_1016_j_ejrad_2022_110361
crossref_primary_10_5114_pjr_2019_85302
crossref_primary_10_1002_cam4_6560
crossref_primary_10_3389_fmed_2024_1511200
crossref_primary_10_1088_1361_6560_ad869f
crossref_primary_10_3390_jpm15040142
crossref_primary_10_3389_fonc_2023_1274716
crossref_primary_10_3390_cancers15215216
crossref_primary_10_1038_s41598_021_81008_x
crossref_primary_10_1148_radiol_2018180767
crossref_primary_10_1016_j_clinimag_2020_09_003
crossref_primary_10_1177_10732748221122703
crossref_primary_10_3390_cancers13235916
crossref_primary_10_3389_fonc_2023_1074060
crossref_primary_10_1111_tbj_14216
crossref_primary_10_1177_10668969241228287
crossref_primary_10_1097_RUQ_0000000000000685
crossref_primary_10_7759_cureus_56515
crossref_primary_10_1016_j_ejrad_2023_111062
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1148/radiol.2017170770
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1527-1315
ExternalDocumentID 29315061
Genre Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: K24 CA194251
– fundername: NCATS NIH HHS
  grantid: UL1 TR000427
GroupedDBID ---
.55
.GJ
123
18M
1CY
1KJ
29P
2WC
34G
39C
4.4
53G
5RE
6NX
6PF
7FM
AAEJM
AAQQT
AAWTL
ABDPE
ABHFT
ABOCM
ACFQH
ACGFO
ACJAN
ACRZS
ADBBV
AENEX
AENYM
AFFNX
AFOSN
AJJEV
AJWWR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
F9R
GX1
H13
J5H
KO8
L7B
LMP
LSO
MJL
MV1
N4W
NPM
OK1
P2P
R.V
RKKAF
RXW
SJN
TAE
TR2
TRS
TWZ
W8F
WH7
WOQ
X7M
YQI
YQJ
ZGI
ZKG
ZVN
ZXP
7X8
ID FETCH-LOGICAL-c399t-ff30e82ad3f50f1b5da7b5d0799e1b6273fbee3577ff22fdb28700c5988a3c232
IEDL.DBID 7X8
ISICitedReferencesCount 54
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000430638800007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1527-1315
IngestDate Fri Sep 05 10:17:20 EDT 2025
Thu Apr 03 07:08:50 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c399t-ff30e82ad3f50f1b5da7b5d0799e1b6273fbee3577ff22fdb28700c5988a3c232
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/6413875
PMID 29315061
PQID 1989554267
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1989554267
pubmed_primary_29315061
PublicationCentury 2000
PublicationDate 2018-05-01
PublicationDateYYYYMMDD 2018-05-01
PublicationDate_xml – month: 05
  year: 2018
  text: 2018-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Radiology
PublicationTitleAlternate Radiology
PublicationYear 2018
SSID ssj0014587
Score 2.4968674
Snippet Purpose To determine the utilization and positive predictive value (PPV) of the American College of Radiology (ACR) Breast Imaging Data and Reporting System...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 416
SubjectTerms Adult
Aged
Aged, 80 and over
Breast Neoplasms - diagnostic imaging
Databases, Factual
Early Detection of Cancer - instrumentation
Female
Humans
Mammography - statistics & numerical data
Middle Aged
Observer Variation
Outcome Assessment (Health Care)
Population Surveillance
Predictive Value of Tests
Radiographic Image Enhancement - methods
Reproducibility of Results
Retrospective Studies
United States
Title ACR BI-RADS Assessment Category 4 Subdivisions in Diagnostic Mammography: Utilization and Outcomes in the National Mammography Database
URI https://www.ncbi.nlm.nih.gov/pubmed/29315061
https://www.proquest.com/docview/1989554267
Volume 287
WOSCitedRecordID wos000430638800007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA6-EC--3w8ieA3d3WyaXS9SW4seWota6K0kmwQKsqvtKvgL_NvO7MbHRRC85JbdkEwy3-SbfEPImRYQSMcmYrFLOIsjLVgaGMV0bLRqxgYxQ1VsQvb7yWiUDvyF28ynVX6eidVBbYoM78gbmNsDri9qyounZ4ZVo5Bd9SU05skiByiDKV1y9M0ixKIqkIeVW1nIQ-FZTYgAGlNlJgVSDyHEM4GUwe8Is_I03bX_jnGdrHqMSVu1UWyQOZtvkuWeZ9G3yHurfUcvb9hdq3NPW1_SnLSNqhHF9I3GFM4TfKiFV2kzOslpp87Igw_SnoL_1DrX53RYTh79S06qckNvX0oYqq36ALSkXnb78Wcv2lGlQu-5TYbdq4f2NfMFGVgGOKZkzvHAJpEy3InAhVoYJaEJZJraUDcBCTltLRdSOhdFzmhkUYNMpEmieAbYbYcs5EVu9wgV1YtdZy3K2UQuVk2thOWKo0ZjZMw-Of2c4jEYPLIYKrfFy2z8Pcn7ZLdep_FTrcwxBuyCionhwR96H5IVWP2kTl48IosOtrs9JkvZazmZTU8qS4K2P-h9AD1J1G0
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ACR+BI-RADS+Assessment+Category+4+Subdivisions+in+Diagnostic+Mammography%3A+Utilization+and+Outcomes+in+the+National+Mammography+Database&rft.jtitle=Radiology&rft.au=Elezaby%2C+Mai&rft.au=Li%2C+Geng&rft.au=Bhargavan-Chatfield%2C+Mythreyi&rft.au=Burnside%2C+Elizabeth+S&rft.date=2018-05-01&rft.issn=1527-1315&rft.eissn=1527-1315&rft.volume=287&rft.issue=2&rft.spage=416&rft_id=info:doi/10.1148%2Fradiol.2017170770&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-1315&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-1315&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-1315&client=summon